Recherche
-
La thrombose au cours des néoplasies myéloprolifératives: Influence de la mutation JAK2V617F
(médecine/sciences. vol. 35, n° 8-9, pp. 651–658, 2019-08)Article de revueLibre accès -
First description of an IgM monoclonal antibody causing αIIb β3 integrin activation and acquired Glanzmann thrombasthenia associated with macrothrombocytopenia
(Journal of Thrombosis and Haemostasis. vol. 17, n° 5, pp. 795–802, 2019-03)Article de revueLibre accès -
Comparison of endothelial promoter efficiency and specificity in mice reveals a subset of Pdgfb-positive hematopoietic cells.
(Journal of Thrombosis and Haemostasis. vol. 17, n° 5, pp. 827-840, 2019-01-01)Article de revueLibre accès -
Vascular endothelial cell expression of JAK2V617F is sufficient to promote a pro-thrombotic state due to increased P-selectin expression
(Haematologica. vol. 104, n° 1, pp. 70–81, 2019-01)Article de revueLibre accès -
Description of a knock-in mouse model of JAK2V617F MPN emerging from a minority of mutated hematopoietic stem cells
(Blood. vol. 134, n° 26, pp. 2383–2387, 2019-12)Article de revueAccès réservé